Investing Profile

Benjamin Kreitman

InvestorVC

Principal at Broadview Ventures

broadviewventures.org/team/Cambridge, Massachusetts
Photo of Benjamin Kreitman, Principal at Broadview Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
HAYA Therapeutics
Seed RoundFeb 2022$5M
Seed RoundMay 2021C18M
Seed RoundJan 2020
$5M
CHF18M
Co-investors: Jens Eckstein (Apollo Health Ventures), Sebastian Bernales (Humboldt Fund)